These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 14678959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ.
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
    Wang X, Pavelic ZP, Li Y, Gleich L, Gartside PS, Pavelic L, Gluckman JL, Stambrook PJ.
    Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
    [Abstract] [Full Text] [Related]

  • 6. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

  • 7. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S.
    Cancer Res; 2001 May 15; 61(10):4122-9. PubMed ID: 11358835
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N.
    Cancer; 1996 Aug 01; 78(3):416-21. PubMed ID: 8697385
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
    Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A, Rao PH.
    Cancer Res; 2001 Jun 01; 61(11):4506-13. PubMed ID: 11389082
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.
    J Am Coll Surg; 2005 Mar 01; 200(3):336-44. PubMed ID: 15737843
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.
    Harpole DH, Moore MB, Herndon JE, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I, Allegra C.
    Clin Cancer Res; 2001 Mar 01; 7(3):562-9. PubMed ID: 11297249
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar 01; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

  • 16. [Glutathione-S-transferase expression in oral squamous cell carcinoma].
    Pannone G, Lo Muzio L, Pappalardo S, Bambini F, Rubini C, Fioroni M, Fanali S.
    Minerva Stomatol; 2000 Mar 01; 49(3):107-17. PubMed ID: 20047209
    [Abstract] [Full Text] [Related]

  • 17. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
    Ishiguro R, Fujii M, Yamashita T, Tashiro M, Tomita T, Ogawa K, Kameyama K.
    Anticancer Res; 2003 Mar 01; 23(6D):5213-20. PubMed ID: 14981992
    [Abstract] [Full Text] [Related]

  • 18. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M, Akpolat I, Kandemir B.
    Saudi Med J; 2003 May 01; 24(5):493-8. PubMed ID: 12847624
    [Abstract] [Full Text] [Related]

  • 19. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I, Nanbu K, Mandai M, Tsuruta Y, Kataoka N, Nagata Y, Mori T.
    Gynecol Oncol; 1998 Sep 01; 70(3):365-71. PubMed ID: 9790789
    [Abstract] [Full Text] [Related]

  • 20. Genome-wide screening for radiation response factors in head and neck cancer.
    Singh B, Kim SH, Carew JF, Yu I, Shaha AR, Wolden S, Boyle J, Shah JP, Rao PH.
    Laryngoscope; 2000 Aug 01; 110(8):1251-6. PubMed ID: 10942121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.